Supernus Pharmaceuticals, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
SUPN on Nasdaq
Location
9715 Key West Avenue, Rockville, MD

Insiders trading volume in the past year

Supernus Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jack A. Khattar President, CEO, Director $110M -$27.7M -20.1% Oct 9, 2025
Charles W. Newhall III Director $5.57M -$1.93M -25.7% Oct 9, 2025
Tami Tillotson Martin Sr. V.P., Regulatory Affairs $2.63M Feb 23, 2024
John M. Siebert Director $2.56M Feb 23, 2024
Frederick M. Hudson Director $2.13M -$632K -22.8% Aug 14, 2025
Carrolee Barlow Director $1.07M Feb 22, 2025
Georges Gemayel Director $919K -$912K -49.8% Feb 22, 2025
Frank Mottola SVP, Chief Tech. Ops. Officer $839K -$1.41M -62.7% Sep 12, 2025
Padmanabh P. Bhatt Sr. VP of IP, CSO $667K -$1.29M -66% Aug 25, 2025
Jonathan Rubin SVP, Chief Medical Officer $607K -$36.3K -5.64% Sep 25, 2025
Timothy C. Dec Senior Vice-President & CFO $254K -$524K -67.4% Aug 22, 2025
Bethany Sensenig Director $178K -$227K -56.1% Aug 14, 2025

Recent Insider Transactions by Companies or Individuals for Supernus Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.